- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06237686
Clinical Investigation Exploring Two Ostomy Product Prototypes
June 25, 2025 updated by: Coloplast A/S
Two ostomy product prototypes (Test product A and B) will be tested in this investigation.
All subjects will test both Test product A and B, with a minimum of 7 days apart. In total, each subject will be enrolled in the investigation for 8 days +3 days.
Study Overview
Study Type
Interventional
Enrollment (Actual)
11
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Humlebæk, Denmark, 3050
- Coloplast A/S
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Has given written informed consent
- Is at least 18 years of age and has full legal capacity
- Has had an ileostomy for more than 3 months
- Has suitable peristomal skin area (assessed by investigator)
- Is currently using flat SenSura Mio 1-piece or 2-piece
- Has used flat SenSura Mio 1-piece or 2-piece for at least 14 days
- Has a stoma size less than 45mm in diameter
Exclusion Criteria:
- Is currently receiving or have within the past 60 days received radio- and/or chemotherapy (Low doses radio- and/or chemotherapy (Assessed by Principal Investigator) is allowed. for indications other than cancer)
- Is currently receiving or have within the past 30 days received topical steroid treatment in the peristomal skin area, e.g. lotion or spray or systemic steroid (tablet/injection) treatment
- Is pregnant or breastfeeding
- Has dermatological problems in the peristomal area (assessed by investigator)
- Participates in other clinical investigations. Exception: Participation in other Coloplast sponsored clinical investigations is accepted under the circumstances that the subject has paused the activities in the investigation and are otherwise complying with the inclusion and exclusion criteria of this protocol
- Has any known allergies towards ingredients in the investigational device
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: one-armed study
|
All subjects will test both Test product A and B, with a minimum of 7 days apart.
In total, each subject will be enrolled in the investigation for 8 days +3 days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Primary Objective
Time Frame: 4 hours
|
Test product A and B's ability to swell around the stoma (assessed by photo/video)
|
4 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 9, 2024
Primary Completion (Actual)
February 2, 2024
Study Completion (Actual)
February 2, 2024
Study Registration Dates
First Submitted
January 2, 2024
First Submitted That Met QC Criteria
January 25, 2024
First Posted (Actual)
February 1, 2024
Study Record Updates
Last Update Posted (Actual)
June 26, 2025
Last Update Submitted That Met QC Criteria
June 25, 2025
Last Verified
June 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- CP363
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.